Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
73,039,333
-
Number of holders
-
45
-
Total 13F shares, excl. options
-
30,695,789
-
Shares change
-
+30,695,789
-
Total reported value, excl. options
-
$601,183,000
-
Value change
-
+$601,183,000
-
Number of buys
-
45
-
Price
-
$19.86
Significant Holders of Ventyx Biosciences, Inc. - Common Stock, par value $0.0001 per share (VTYX) as of Q4 2021
45 filings reported holding VTYX - Ventyx Biosciences, Inc. - Common Stock, par value $0.0001 per share as of Q4 2021.
Ventyx Biosciences, Inc. - Common Stock, par value $0.0001 per share (VTYX) has 45 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 30,695,789 shares
of 73,039,333 outstanding shares and own 42.03% of the company stock.
Largest 10 shareholders include venBio Partners LLC (5,011,536 shares), Third Point LLC (4,312,834 shares), CITADEL ADVISORS LLC (3,891,028 shares), JANUS HENDERSON GROUP PLC (2,166,532 shares), WELLINGTON MANAGEMENT GROUP LLP (1,828,528 shares), Logos Global Management LP (1,824,280 shares), Vivo Capital, LLC (1,791,275 shares), RTW INVESTMENTS, LP (1,551,778 shares), EcoR1 Capital, LLC (1,300,000 shares), and ORBIMED ADVISORS LLC (1,289,280 shares).
This table shows the top 45 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.